PAOLINI PAOLETTI, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 510
EU - Europa 252
AS - Asia 154
Totale 916
Nazione #
US - Stati Uniti d'America 509
IE - Irlanda 104
HK - Hong Kong 73
IT - Italia 67
SG - Singapore 42
CN - Cina 32
RO - Romania 20
FI - Finlandia 16
DE - Germania 15
RU - Federazione Russa 6
GB - Regno Unito 5
VN - Vietnam 5
FR - Francia 4
UA - Ucraina 4
AT - Austria 2
CH - Svizzera 2
SE - Svezia 2
BE - Belgio 1
CA - Canada 1
ES - Italia 1
JP - Giappone 1
KR - Corea 1
MD - Moldavia 1
NL - Olanda 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 916
Città #
Chandler 167
Dublin 104
Hong Kong 72
San Mateo 35
Perugia 30
Singapore 26
Timisoara 19
Lawrence 18
Medford 18
Princeton 18
Wilmington 17
Altamura 14
Helsinki 14
Falls Church 13
Andover 12
Boardman 12
Des Moines 12
Ashburn 11
Redwood City 10
Beijing 6
Los Angeles 6
Dong Ket 5
Fairfield 5
Redmond 5
Saint Petersburg 4
Cosenza 3
El Paso 3
Milan 3
Rome 3
San Paolo di Civitate 3
Brixen 2
Chicago 2
Genoa 2
Lappeenranta 2
Munich 2
New York 2
Amsterdam 1
Ann Arbor 1
Brussels 1
Böblingen 1
Chisinau 1
Frankfurt am Main 1
Fremont 1
Houston 1
Madrid 1
Montespertoli 1
Norwalk 1
Radeberg 1
Seattle 1
Secaucus 1
Seoul 1
Shanghai 1
Tappahannock 1
Tokyo 1
Trento 1
Vancouver 1
Wuhan 1
Zwenkau 1
Totale 702
Nome #
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 68
Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study 52
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies 52
Unraveling Pathophysiological Mechanisms of Parkinson’s Disease: Contribution of CSF Biomarkers 49
Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation 45
Changes of olfactory tract in Parkinson’s disease: a DTI tractography study 45
Molecular profiling in Parkinsonian syndromes: CSF biomarkers 44
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ? 43
Levodopa-responsive breathing discomfort in Parkinson’s disease patients 41
PEG-J replacement for duodenal levodopa infusion in Parkinson's disease patients: a retrospective study 41
Risk factors of levodopa-induced dyskinesia in Parkinson's disease: results from the PPMI cohort 40
T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson's disease 39
The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF Biomarkers. 37
Drug-induced Creutzfeldt-Jakob disease-like syndrome: Early CSF analysis as useful tool for differential diagnosis 34
Levodopa treatment in Parkinson's disease: earlier or later? 34
Specific Cerebrospinal Fluid SerpinA1 Isoform Pattern in Alzheimer's Disease 33
Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington's and Parkinson's disease 32
High performance liquid chromatography determination of L-glutamate, L-glutamine and glycine content in brain, cerebrospinal fluid and blood serum of patients affected by Alzheimer's disease 32
Blood biomarkers may distinguish among dementia disorders 25
Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer's disease 25
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation 22
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers 19
α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward 19
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 15
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders 12
Association between Neuropsychological Performance and CSF Profile in Subjective Cognitive Decline: Towards the Diagnosis of Preclinical AD 11
LRRK2 Quantification in Cerebrospinal Fluid of Patients with Parkinson's Disease and Atypical Parkinsonian Syndromes 11
CSF Synaptic Biomarkers in AT(N)-Based Subgroups of Lewy Body Disease 11
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay 10
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts 10
Predictive value for cerebrospinal fluid Alzheimer's disease profile of different measures of verbal episodic memory in patients with MCI 5
Required improvements for cerebrospinal fluid-based biomarker tests of Alzheimer's disease 4
Hyposmia correlates with axial signs and gait disorder in Parkinson's disease: an Italian Olfactory Identification Test study 4
Incidence and Risk Factors Epilepsy in Patients with Dementia: A Population-Based Study Using Regional Healthcare Databases in Umbria 3
Totale 967
Categoria #
all - tutte 4.784
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.784


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202018 0 0 0 0 1 0 0 0 4 5 8 0
2020/202189 0 0 1 4 51 8 4 3 2 8 2 6
2021/2022134 0 23 0 0 5 8 4 34 10 11 20 19
2022/2023467 19 104 7 35 41 51 1 27 154 5 14 9
2023/2024253 16 25 8 4 4 2 42 6 46 12 45 43
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 967